| # | Country | Total Patents | |
|---|---|---|---|
| #1 | EPO (European Patent Office) | 4 | |
| #2 | Canada | 2 | |
| #3 | China | 2 | |
| #4 | Republic of Korea | 2 | |
| #5 | United States | 2 | |
| #6 | WIPO (World Intellectual Property Organization) | 2 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology |
| # | Technology | |
|---|---|---|
| #1 | Microorganisms | |
| #2 | Medical preparations | |
| #3 | Therapeutic chemical compounds | |
| #4 | Peptides |
| # | Name | Total Patents |
|---|---|---|
| #1 | Spanholtz Jan | 14 |
| #2 | Jongen Wim | 5 |
| #3 | Gatti Alessandra | 5 |
| #4 | Vallanti Giuliana | 5 |
| #5 | Traversari Catia | 5 |
| #6 | Kok Nina | 5 |
| #7 | Dolstra Harmen | 3 |
| #8 | Huppert Volker | 1 |
| #9 | Raimo Monica | 1 |
| Publication | Filing date | Title |
|---|---|---|
| WO2021015615A1 | Low density cell culture | |
| KR20210016567A | CAR NK cells | |
| CN108697737A | The composition used in immunotherapy | |
| EP2812011A1 | Ex vivo nk cell differentiation from cd34+ hematopoietic cells | |
| EP2686421A1 | Generation of nk cells and nk-cell progenitors |